Publications of Pavel Marichal-Gallardo

Marichal-Gallardo, P., Genzel, Y., Börner, K., Grimm, D., Wolff, M. W., & Reichl, U.A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccinesPresented at: ECI Advancing Manufacture of Cell and Gene Therapies VICoronado, United States of America, January 27, 2019.

Nikolay, A., Tapia, F., Marichal-Gallardo, P., Pralow, A., Hoffmann, M., Rapp, E., Genzel, Y., & Reichl, U.Moderne Methoden der ImpfstoffherstellungPresented at: Wissenschaft im RathausMagdeburg, Germany, September 30, 2019.

Nikolay, A., Tapia, F., Marichal-Gallardo, P., Pralow, A., Hoffmann, M., Rapp, E., Genzel, Y., & Reichl, U.Cell Culture-based Viral Vaccines: Process Intensification and MonitoringPresented at: Cuba Symposium “Frontiers of Science”Havanna, Cuba, March 5, 2019.

Tapia, F., Marichal-Gallardo, P., & Reichl, U.A universal platform for continuous manufacturing of viral vaccines & gene therapy vectorsPresented at: Workshop BioverfahrenstechnikLeuna, Germany, September 19, 2019.

Marichal-Gallardo, P., Genzel, Y., Börner, K., Grimm, D., Wolff, M. W., & Reichl, U.A single-use purification platform for viral vaccines & gene therapy vectorsPresented at: International Symposium on the Separation of Proteins, Peptides, and Polynucleotides (ISPPP) 2018Berlin, Germany, November 3, 2018.

Marichal-Gallardo, P., Lothert, K., Grein, T., Reichl, U., Czermak, P., & Wolff, M. W.Single-use purification of cell culture-based virus particles by steric exclusion chromatographyPresented at: National Meeting of the American Chemical Society (ACS)New Orleans, USA, March 18, 2018.

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Baelkner, M., Julia D. Boehme, J. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 32^nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Baelkner, M., Julia D. Boehme, J. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 8^th European Congress of VirologyGdańsk (Poland), May 4, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Hein, M. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivoPresented at: Cell Culture Engineering (CCE) XVIII Cancun (Mexico), April 23, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Marichal-Gallardo, P., Hein, M. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo StudiesPresented at: Himmelfahrtstagung on Bioprocess Engineering 2023Weimar (Germany), May 15, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Marichal-Gallardo, P., Hein, M. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral EfficacyPresented at: 32^nd Annual Meeting of the Society for Virology (GFV)Ulm (Germany), March 25, 2023.

Kupke, S. Y., Hein, M. D., Bdeir, N., Rand, U., Marichal-Gallardo, P., Cicin-Sain, L., Bruder, D., Pöhlmann, S., Schughart, K., & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: 31st Annual Meeting of the Society for Virologyonline, March 30, 2022.

Kupke, S. Y., Hein, M., Bdeir, N., Rand, U., Marichal-Gallardo, P., Cicin-Sain, L., Bruder, D., Pöhlmann, S., Schughart, K., & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Kupke, S. Y., Hein, M. D., Kollmus, H., Marichal-Gallardo, P., Schughart, K., & Reichl, U.The novel influenza A virus defective interfering particle "OP7" as an antiviral agent: discovery, production, and animal trialsPresented at: The seventh ESWI Influenza ConferenceVirtual Meeting, December 6, 2020.

Wolff, M. W., Marichal-Gallardo, P., Lothert, K., Riedel, D., Börner, K., Fortuna, A. R., Czermak, P., & Reichl, U.A step towards globally affordable vaccines & gene therapies: Steric exclusion chromatography as a capture platformPresented at: Recovery of Biological ProductsAsheville, USA, October 7, 2018.

Marichal-Gallardo, P. (2019)Chromatographic purification of biological macromolecules by their capture on hydrophilic surfaces with the aid of non-ionic polymersPhD Thesis, Otto-von-Guericke-Universität, Magdeburgdoi: 10.25673/33035.

Wolff, M. W., Pieler, M., Reichl, U., & Marichal-Gallardo, P. (2019)Method for the Separation of Virus Compositions Including Depletion and Purification thereof.